Global Oral Vaccine Adjuvants Supply, Demand and Key Producers, 2023-2029

Page: 118

Published Date: 07 Aug 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Oral Vaccine Adjuvants market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Vaccine adjuvants (Adjuvant) are a class of substances that can non-specifically change or enhance the body's specific immune response to antigens and play an auxiliary role. Adjuvants can induce the body to produce a long-term and efficient specific immune response, improve the body's protective ability, and at the same time reduce the dosage of immune substances and reduce the production cost of vaccines.

This report studies the global Oral Vaccine Adjuvants production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Vaccine Adjuvants, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Vaccine Adjuvants that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oral Vaccine Adjuvants total production and demand, 2018-2029, (K Units)
Global Oral Vaccine Adjuvants total production value, 2018-2029, (USD Million)
Global Oral Vaccine Adjuvants production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oral Vaccine Adjuvants consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Oral Vaccine Adjuvants domestic production, consumption, key domestic manufacturers and share
Global Oral Vaccine Adjuvants production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Oral Vaccine Adjuvants production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oral Vaccine Adjuvants production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Oral Vaccine Adjuvants market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SEPPIC, SDA BIO, Croda International, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Vaccine Adjuvants market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oral Vaccine Adjuvants Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Oral Vaccine Adjuvants Market, Segmentation by Type
Veterinary Vaccine Adjuvants
Human Vaccine Adjuvants

Global Oral Vaccine Adjuvants Market, Segmentation by Application
Research Application
Commercial Application

Companies Profiled:
SEPPIC
SDA BIO
Croda International
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

Key Questions Answered
1. How big is the global Oral Vaccine Adjuvants market?
2. What is the demand of the global Oral Vaccine Adjuvants market?
3. What is the year over year growth of the global Oral Vaccine Adjuvants market?
4. What is the production and production value of the global Oral Vaccine Adjuvants market?
5. Who are the key producers in the global Oral Vaccine Adjuvants market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oral Vaccine Adjuvants Introduction
    1.2 World Oral Vaccine Adjuvants Supply & Forecast
        1.2.1 World Oral Vaccine Adjuvants Production Value (2018 & 2022 & 2029)
        1.2.2 World Oral Vaccine Adjuvants Production (2018-2029)
        1.2.3 World Oral Vaccine Adjuvants Pricing Trends (2018-2029)
    1.3 World Oral Vaccine Adjuvants Production by Region (Based on Production Site)
        1.3.1 World Oral Vaccine Adjuvants Production Value by Region (2018-2029)
        1.3.2 World Oral Vaccine Adjuvants Production by Region (2018-2029)
        1.3.3 World Oral Vaccine Adjuvants Average Price by Region (2018-2029)
        1.3.4 North America Oral Vaccine Adjuvants Production (2018-2029)
        1.3.5 Europe Oral Vaccine Adjuvants Production (2018-2029)
        1.3.6 China Oral Vaccine Adjuvants Production (2018-2029)
        1.3.7 Japan Oral Vaccine Adjuvants Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oral Vaccine Adjuvants Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oral Vaccine Adjuvants Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Oral Vaccine Adjuvants Demand (2018-2029)
    2.2 World Oral Vaccine Adjuvants Consumption by Region
        2.2.1 World Oral Vaccine Adjuvants Consumption by Region (2018-2023)
        2.2.2 World Oral Vaccine Adjuvants Consumption Forecast by Region (2024-2029)
    2.3 United States Oral Vaccine Adjuvants Consumption (2018-2029)
    2.4 China Oral Vaccine Adjuvants Consumption (2018-2029)
    2.5 Europe Oral Vaccine Adjuvants Consumption (2018-2029)
    2.6 Japan Oral Vaccine Adjuvants Consumption (2018-2029)
    2.7 South Korea Oral Vaccine Adjuvants Consumption (2018-2029)
    2.8 ASEAN Oral Vaccine Adjuvants Consumption (2018-2029)
    2.9 India Oral Vaccine Adjuvants Consumption (2018-2029)

3 World Oral Vaccine Adjuvants Manufacturers Competitive Analysis
    3.1 World Oral Vaccine Adjuvants Production Value by Manufacturer (2018-2023)
    3.2 World Oral Vaccine Adjuvants Production by Manufacturer (2018-2023)
    3.3 World Oral Vaccine Adjuvants Average Price by Manufacturer (2018-2023)
    3.4 Oral Vaccine Adjuvants Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Oral Vaccine Adjuvants Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Oral Vaccine Adjuvants in 2022
        3.5.3 Global Concentration Ratios (CR8) for Oral Vaccine Adjuvants in 2022
    3.6 Oral Vaccine Adjuvants Market: Overall Company Footprint Analysis
        3.6.1 Oral Vaccine Adjuvants Market: Region Footprint
        3.6.2 Oral Vaccine Adjuvants Market: Company Product Type Footprint
        3.6.3 Oral Vaccine Adjuvants Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Oral Vaccine Adjuvants Production Value Comparison
        4.1.1 United States VS China: Oral Vaccine Adjuvants Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Oral Vaccine Adjuvants Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Oral Vaccine Adjuvants Production Comparison
        4.2.1 United States VS China: Oral Vaccine Adjuvants Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Oral Vaccine Adjuvants Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Oral Vaccine Adjuvants Consumption Comparison
        4.3.1 United States VS China: Oral Vaccine Adjuvants Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Oral Vaccine Adjuvants Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Oral Vaccine Adjuvants Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Oral Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Oral Vaccine Adjuvants Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Oral Vaccine Adjuvants Production (2018-2023)
    4.5 China Based Oral Vaccine Adjuvants Manufacturers and Market Share
        4.5.1 China Based Oral Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Oral Vaccine Adjuvants Production Value (2018-2023)
        4.5.3 China Based Manufacturers Oral Vaccine Adjuvants Production (2018-2023)
    4.6 Rest of World Based Oral Vaccine Adjuvants Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Oral Vaccine Adjuvants Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Oral Vaccine Adjuvants Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Oral Vaccine Adjuvants Production (2018-2023)

5 Market Analysis by Type
    5.1 World Oral Vaccine Adjuvants Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Veterinary Vaccine Adjuvants
        5.2.2 Human Vaccine Adjuvants
    5.3 Market Segment by Type
        5.3.1 World Oral Vaccine Adjuvants Production by Type (2018-2029)
        5.3.2 World Oral Vaccine Adjuvants Production Value by Type (2018-2029)
        5.3.3 World Oral Vaccine Adjuvants Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Oral Vaccine Adjuvants Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Research Application
        6.2.2 Commercial Application
    6.3 Market Segment by Application
        6.3.1 World Oral Vaccine Adjuvants Production by Application (2018-2029)
        6.3.2 World Oral Vaccine Adjuvants Production Value by Application (2018-2029)
        6.3.3 World Oral Vaccine Adjuvants Average Price by Application (2018-2029)

7 Company Profiles
    7.1 SEPPIC
        7.1.1 SEPPIC Details
        7.1.2 SEPPIC Major Business
        7.1.3 SEPPIC Oral Vaccine Adjuvants Product and Services
        7.1.4 SEPPIC Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 SEPPIC Recent Developments/Updates
        7.1.6 SEPPIC Competitive Strengths & Weaknesses
    7.2 SDA BIO
        7.2.1 SDA BIO Details
        7.2.2 SDA BIO Major Business
        7.2.3 SDA BIO Oral Vaccine Adjuvants Product and Services
        7.2.4 SDA BIO Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 SDA BIO Recent Developments/Updates
        7.2.6 SDA BIO Competitive Strengths & Weaknesses
    7.3 Croda International
        7.3.1 Croda International Details
        7.3.2 Croda International Major Business
        7.3.3 Croda International Oral Vaccine Adjuvants Product and Services
        7.3.4 Croda International Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Croda International Recent Developments/Updates
        7.3.6 Croda International Competitive Strengths & Weaknesses
    7.4 SPI Pharma
        7.4.1 SPI Pharma Details
        7.4.2 SPI Pharma Major Business
        7.4.3 SPI Pharma Oral Vaccine Adjuvants Product and Services
        7.4.4 SPI Pharma Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 SPI Pharma Recent Developments/Updates
        7.4.6 SPI Pharma Competitive Strengths & Weaknesses
    7.5 Phibro Animal Health Corporation
        7.5.1 Phibro Animal Health Corporation Details
        7.5.2 Phibro Animal Health Corporation Major Business
        7.5.3 Phibro Animal Health Corporation Oral Vaccine Adjuvants Product and Services
        7.5.4 Phibro Animal Health Corporation Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Phibro Animal Health Corporation Recent Developments/Updates
        7.5.6 Phibro Animal Health Corporation Competitive Strengths & Weaknesses
    7.6 Tj Kaiwei
        7.6.1 Tj Kaiwei Details
        7.6.2 Tj Kaiwei Major Business
        7.6.3 Tj Kaiwei Oral Vaccine Adjuvants Product and Services
        7.6.4 Tj Kaiwei Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Tj Kaiwei Recent Developments/Updates
        7.6.6 Tj Kaiwei Competitive Strengths & Weaknesses
    7.7 Novavax
        7.7.1 Novavax Details
        7.7.2 Novavax Major Business
        7.7.3 Novavax Oral Vaccine Adjuvants Product and Services
        7.7.4 Novavax Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Novavax Recent Developments/Updates
        7.7.6 Novavax Competitive Strengths & Weaknesses
    7.8 Zhuoyue
        7.8.1 Zhuoyue Details
        7.8.2 Zhuoyue Major Business
        7.8.3 Zhuoyue Oral Vaccine Adjuvants Product and Services
        7.8.4 Zhuoyue Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Zhuoyue Recent Developments/Updates
        7.8.6 Zhuoyue Competitive Strengths & Weaknesses
    7.9 Aphios
        7.9.1 Aphios Details
        7.9.2 Aphios Major Business
        7.9.3 Aphios Oral Vaccine Adjuvants Product and Services
        7.9.4 Aphios Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Aphios Recent Developments/Updates
        7.9.6 Aphios Competitive Strengths & Weaknesses
    7.10 GSK
        7.10.1 GSK Details
        7.10.2 GSK Major Business
        7.10.3 GSK Oral Vaccine Adjuvants Product and Services
        7.10.4 GSK Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 GSK Recent Developments/Updates
        7.10.6 GSK Competitive Strengths & Weaknesses
    7.11 CSL
        7.11.1 CSL Details
        7.11.2 CSL Major Business
        7.11.3 CSL Oral Vaccine Adjuvants Product and Services
        7.11.4 CSL Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 CSL Recent Developments/Updates
        7.11.6 CSL Competitive Strengths & Weaknesses
    7.12 Brenntag Biosector
        7.12.1 Brenntag Biosector Details
        7.12.2 Brenntag Biosector Major Business
        7.12.3 Brenntag Biosector Oral Vaccine Adjuvants Product and Services
        7.12.4 Brenntag Biosector Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Brenntag Biosector Recent Developments/Updates
        7.12.6 Brenntag Biosector Competitive Strengths & Weaknesses
    7.13 SEPPIC
        7.13.1 SEPPIC Details
        7.13.2 SEPPIC Major Business
        7.13.3 SEPPIC Oral Vaccine Adjuvants Product and Services
        7.13.4 SEPPIC Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 SEPPIC Recent Developments/Updates
        7.13.6 SEPPIC Competitive Strengths & Weaknesses
    7.14 SPI Pharma
        7.14.1 SPI Pharma Details
        7.14.2 SPI Pharma Major Business
        7.14.3 SPI Pharma Oral Vaccine Adjuvants Product and Services
        7.14.4 SPI Pharma Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 SPI Pharma Recent Developments/Updates
        7.14.6 SPI Pharma Competitive Strengths & Weaknesses
    7.15 Novavax
        7.15.1 Novavax Details
        7.15.2 Novavax Major Business
        7.15.3 Novavax Oral Vaccine Adjuvants Product and Services
        7.15.4 Novavax Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Novavax Recent Developments/Updates
        7.15.6 Novavax Competitive Strengths & Weaknesses
    7.16 Avanti Polar Lipids
        7.16.1 Avanti Polar Lipids Details
        7.16.2 Avanti Polar Lipids Major Business
        7.16.3 Avanti Polar Lipids Oral Vaccine Adjuvants Product and Services
        7.16.4 Avanti Polar Lipids Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Avanti Polar Lipids Recent Developments/Updates
        7.16.6 Avanti Polar Lipids Competitive Strengths & Weaknesses
    7.17 Aphios
        7.17.1 Aphios Details
        7.17.2 Aphios Major Business
        7.17.3 Aphios Oral Vaccine Adjuvants Product and Services
        7.17.4 Aphios Oral Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Aphios Recent Developments/Updates
        7.17.6 Aphios Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oral Vaccine Adjuvants Industry Chain
    8.2 Oral Vaccine Adjuvants Upstream Analysis
        8.2.1 Oral Vaccine Adjuvants Core Raw Materials
        8.2.2 Main Manufacturers of Oral Vaccine Adjuvants Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Oral Vaccine Adjuvants Production Mode
    8.6 Oral Vaccine Adjuvants Procurement Model
    8.7 Oral Vaccine Adjuvants Industry Sales Model and Sales Channels
        8.7.1 Oral Vaccine Adjuvants Sales Model
        8.7.2 Oral Vaccine Adjuvants Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oral Vaccine Adjuvants Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Oral Vaccine Adjuvants Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Oral Vaccine Adjuvants Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Oral Vaccine Adjuvants Production Value Market Share by Region (2018-2023)
    Table 5. World Oral Vaccine Adjuvants Production Value Market Share by Region (2024-2029)
    Table 6. World Oral Vaccine Adjuvants Production by Region (2018-2023) & (K Units)
    Table 7. World Oral Vaccine Adjuvants Production by Region (2024-2029) & (K Units)
    Table 8. World Oral Vaccine Adjuvants Production Market Share by Region (2018-2023)
    Table 9. World Oral Vaccine Adjuvants Production Market Share by Region (2024-2029)
    Table 10. World Oral Vaccine Adjuvants Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Oral Vaccine Adjuvants Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Oral Vaccine Adjuvants Major Market Trends
    Table 13. World Oral Vaccine Adjuvants Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Oral Vaccine Adjuvants Consumption by Region (2018-2023) & (K Units)
    Table 15. World Oral Vaccine Adjuvants Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Oral Vaccine Adjuvants Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Oral Vaccine Adjuvants Producers in 2022
    Table 18. World Oral Vaccine Adjuvants Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Oral Vaccine Adjuvants Producers in 2022
    Table 20. World Oral Vaccine Adjuvants Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Oral Vaccine Adjuvants Company Evaluation Quadrant
    Table 22. World Oral Vaccine Adjuvants Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Oral Vaccine Adjuvants Production Site of Key Manufacturer
    Table 24. Oral Vaccine Adjuvants Market: Company Product Type Footprint
    Table 25. Oral Vaccine Adjuvants Market: Company Product Application Footprint
    Table 26. Oral Vaccine Adjuvants Competitive Factors
    Table 27. Oral Vaccine Adjuvants New Entrant and Capacity Expansion Plans
    Table 28. Oral Vaccine Adjuvants Mergers & Acquisitions Activity
    Table 29. United States VS China Oral Vaccine Adjuvants Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Oral Vaccine Adjuvants Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Oral Vaccine Adjuvants Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Oral Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Oral Vaccine Adjuvants Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Oral Vaccine Adjuvants Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Oral Vaccine Adjuvants Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Oral Vaccine Adjuvants Production Market Share (2018-2023)
    Table 37. China Based Oral Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Oral Vaccine Adjuvants Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Oral Vaccine Adjuvants Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Oral Vaccine Adjuvants Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Oral Vaccine Adjuvants Production Market Share (2018-2023)
    Table 42. Rest of World Based Oral Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Oral Vaccine Adjuvants Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Oral Vaccine Adjuvants Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Oral Vaccine Adjuvants Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Oral Vaccine Adjuvants Production Market Share (2018-2023)
    Table 47. World Oral Vaccine Adjuvants Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Oral Vaccine Adjuvants Production by Type (2018-2023) & (K Units)
    Table 49. World Oral Vaccine Adjuvants Production by Type (2024-2029) & (K Units)
    Table 50. World Oral Vaccine Adjuvants Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Oral Vaccine Adjuvants Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Oral Vaccine Adjuvants Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Oral Vaccine Adjuvants Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Oral Vaccine Adjuvants Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Oral Vaccine Adjuvants Production by Application (2018-2023) & (K Units)
    Table 56. World Oral Vaccine Adjuvants Production by Application (2024-2029) & (K Units)
    Table 57. World Oral Vaccine Adjuvants Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Oral Vaccine Adjuvants Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Oral Vaccine Adjuvants Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Oral Vaccine Adjuvants Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. SEPPIC Basic Information, Manufacturing Base and Competitors
    Table 62. SEPPIC Major Business
    Table 63. SEPPIC Oral Vaccine Adjuvants Product and Services
    Table 64. SEPPIC Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. SEPPIC Recent Developments/Updates
    Table 66. SEPPIC Competitive Strengths & Weaknesses
    Table 67. SDA BIO Basic Information, Manufacturing Base and Competitors
    Table 68. SDA BIO Major Business
    Table 69. SDA BIO Oral Vaccine Adjuvants Product and Services
    Table 70. SDA BIO Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. SDA BIO Recent Developments/Updates
    Table 72. SDA BIO Competitive Strengths & Weaknesses
    Table 73. Croda International Basic Information, Manufacturing Base and Competitors
    Table 74. Croda International Major Business
    Table 75. Croda International Oral Vaccine Adjuvants Product and Services
    Table 76. Croda International Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Croda International Recent Developments/Updates
    Table 78. Croda International Competitive Strengths & Weaknesses
    Table 79. SPI Pharma Basic Information, Manufacturing Base and Competitors
    Table 80. SPI Pharma Major Business
    Table 81. SPI Pharma Oral Vaccine Adjuvants Product and Services
    Table 82. SPI Pharma Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. SPI Pharma Recent Developments/Updates
    Table 84. SPI Pharma Competitive Strengths & Weaknesses
    Table 85. Phibro Animal Health Corporation Basic Information, Manufacturing Base and Competitors
    Table 86. Phibro Animal Health Corporation Major Business
    Table 87. Phibro Animal Health Corporation Oral Vaccine Adjuvants Product and Services
    Table 88. Phibro Animal Health Corporation Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Phibro Animal Health Corporation Recent Developments/Updates
    Table 90. Phibro Animal Health Corporation Competitive Strengths & Weaknesses
    Table 91. Tj Kaiwei Basic Information, Manufacturing Base and Competitors
    Table 92. Tj Kaiwei Major Business
    Table 93. Tj Kaiwei Oral Vaccine Adjuvants Product and Services
    Table 94. Tj Kaiwei Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Tj Kaiwei Recent Developments/Updates
    Table 96. Tj Kaiwei Competitive Strengths & Weaknesses
    Table 97. Novavax Basic Information, Manufacturing Base and Competitors
    Table 98. Novavax Major Business
    Table 99. Novavax Oral Vaccine Adjuvants Product and Services
    Table 100. Novavax Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Novavax Recent Developments/Updates
    Table 102. Novavax Competitive Strengths & Weaknesses
    Table 103. Zhuoyue Basic Information, Manufacturing Base and Competitors
    Table 104. Zhuoyue Major Business
    Table 105. Zhuoyue Oral Vaccine Adjuvants Product and Services
    Table 106. Zhuoyue Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Zhuoyue Recent Developments/Updates
    Table 108. Zhuoyue Competitive Strengths & Weaknesses
    Table 109. Aphios Basic Information, Manufacturing Base and Competitors
    Table 110. Aphios Major Business
    Table 111. Aphios Oral Vaccine Adjuvants Product and Services
    Table 112. Aphios Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Aphios Recent Developments/Updates
    Table 114. Aphios Competitive Strengths & Weaknesses
    Table 115. GSK Basic Information, Manufacturing Base and Competitors
    Table 116. GSK Major Business
    Table 117. GSK Oral Vaccine Adjuvants Product and Services
    Table 118. GSK Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. GSK Recent Developments/Updates
    Table 120. GSK Competitive Strengths & Weaknesses
    Table 121. CSL Basic Information, Manufacturing Base and Competitors
    Table 122. CSL Major Business
    Table 123. CSL Oral Vaccine Adjuvants Product and Services
    Table 124. CSL Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. CSL Recent Developments/Updates
    Table 126. CSL Competitive Strengths & Weaknesses
    Table 127. Brenntag Biosector Basic Information, Manufacturing Base and Competitors
    Table 128. Brenntag Biosector Major Business
    Table 129. Brenntag Biosector Oral Vaccine Adjuvants Product and Services
    Table 130. Brenntag Biosector Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Brenntag Biosector Recent Developments/Updates
    Table 132. Brenntag Biosector Competitive Strengths & Weaknesses
    Table 133. SEPPIC Basic Information, Manufacturing Base and Competitors
    Table 134. SEPPIC Major Business
    Table 135. SEPPIC Oral Vaccine Adjuvants Product and Services
    Table 136. SEPPIC Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. SEPPIC Recent Developments/Updates
    Table 138. SEPPIC Competitive Strengths & Weaknesses
    Table 139. SPI Pharma Basic Information, Manufacturing Base and Competitors
    Table 140. SPI Pharma Major Business
    Table 141. SPI Pharma Oral Vaccine Adjuvants Product and Services
    Table 142. SPI Pharma Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. SPI Pharma Recent Developments/Updates
    Table 144. SPI Pharma Competitive Strengths & Weaknesses
    Table 145. Novavax Basic Information, Manufacturing Base and Competitors
    Table 146. Novavax Major Business
    Table 147. Novavax Oral Vaccine Adjuvants Product and Services
    Table 148. Novavax Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Novavax Recent Developments/Updates
    Table 150. Novavax Competitive Strengths & Weaknesses
    Table 151. Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
    Table 152. Avanti Polar Lipids Major Business
    Table 153. Avanti Polar Lipids Oral Vaccine Adjuvants Product and Services
    Table 154. Avanti Polar Lipids Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Avanti Polar Lipids Recent Developments/Updates
    Table 156. Aphios Basic Information, Manufacturing Base and Competitors
    Table 157. Aphios Major Business
    Table 158. Aphios Oral Vaccine Adjuvants Product and Services
    Table 159. Aphios Oral Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 160. Global Key Players of Oral Vaccine Adjuvants Upstream (Raw Materials)
    Table 161. Oral Vaccine Adjuvants Typical Customers
    Table 162. Oral Vaccine Adjuvants Typical Distributors
List of Figure
    Figure 1. Oral Vaccine Adjuvants Picture
    Figure 2. World Oral Vaccine Adjuvants Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Oral Vaccine Adjuvants Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Oral Vaccine Adjuvants Production (2018-2029) & (K Units)
    Figure 5. World Oral Vaccine Adjuvants Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Oral Vaccine Adjuvants Production Value Market Share by Region (2018-2029)
    Figure 7. World Oral Vaccine Adjuvants Production Market Share by Region (2018-2029)
    Figure 8. North America Oral Vaccine Adjuvants Production (2018-2029) & (K Units)
    Figure 9. Europe Oral Vaccine Adjuvants Production (2018-2029) & (K Units)
    Figure 10. China Oral Vaccine Adjuvants Production (2018-2029) & (K Units)
    Figure 11. Japan Oral Vaccine Adjuvants Production (2018-2029) & (K Units)
    Figure 12. Oral Vaccine Adjuvants Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Oral Vaccine Adjuvants Consumption (2018-2029) & (K Units)
    Figure 15. World Oral Vaccine Adjuvants Consumption Market Share by Region (2018-2029)
    Figure 16. United States Oral Vaccine Adjuvants Consumption (2018-2029) & (K Units)
    Figure 17. China Oral Vaccine Adjuvants Consumption (2018-2029) & (K Units)
    Figure 18. Europe Oral Vaccine Adjuvants Consumption (2018-2029) & (K Units)
    Figure 19. Japan Oral Vaccine Adjuvants Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Oral Vaccine Adjuvants Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Oral Vaccine Adjuvants Consumption (2018-2029) & (K Units)
    Figure 22. India Oral Vaccine Adjuvants Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Oral Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Vaccine Adjuvants Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Vaccine Adjuvants Markets in 2022
    Figure 26. United States VS China: Oral Vaccine Adjuvants Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Oral Vaccine Adjuvants Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Oral Vaccine Adjuvants Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Oral Vaccine Adjuvants Production Market Share 2022
    Figure 30. China Based Manufacturers Oral Vaccine Adjuvants Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Oral Vaccine Adjuvants Production Market Share 2022
    Figure 32. World Oral Vaccine Adjuvants Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Oral Vaccine Adjuvants Production Value Market Share by Type in 2022
    Figure 34. Veterinary Vaccine Adjuvants
    Figure 35. Human Vaccine Adjuvants
    Figure 36. World Oral Vaccine Adjuvants Production Market Share by Type (2018-2029)
    Figure 37. World Oral Vaccine Adjuvants Production Value Market Share by Type (2018-2029)
    Figure 38. World Oral Vaccine Adjuvants Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Oral Vaccine Adjuvants Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Oral Vaccine Adjuvants Production Value Market Share by Application in 2022
    Figure 41. Research Application
    Figure 42. Commercial Application
    Figure 43. World Oral Vaccine Adjuvants Production Market Share by Application (2018-2029)
    Figure 44. World Oral Vaccine Adjuvants Production Value Market Share by Application (2018-2029)
    Figure 45. World Oral Vaccine Adjuvants Average Price by Application (2018-2029) & (US$/Unit)
    Figure 46. Oral Vaccine Adjuvants Industry Chain
    Figure 47. Oral Vaccine Adjuvants Procurement Model
    Figure 48. Oral Vaccine Adjuvants Sales Model
    Figure 49. Oral Vaccine Adjuvants Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

SEPPIC
SDA BIO
Croda International
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

Related Reports

Global Oral Vaccine Adjuvants Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Oral Vaccine Adjuvants Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 07 Aug 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Oral Vaccine Adjuvants market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Oral Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Oral Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Oral Vaccine Adjuvants market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Oral Vaccine Adjuvants

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>